Status:
UNKNOWN
Trans-anal Versus Laparoscopic TME for Mid and Low Rectal Cancer
Lead Sponsor:
Mansoura University
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study is designed to assess the surgical, oncological and functional outcome of either the laparoscopic or trans-anal TME in management of mid and low rectal cancer.
Detailed Description
Colorectal cancer (CRC) is considered the third most common type of cancer all over the world and the fourth common cause of cancer-specific mortality.Surgical management for rectal cancer is challeng...
Eligibility Criteria
Inclusion
- Anesthetically fit patient.
- Non metastatic pathologically proven rectal cancer (Mid-Low).
- Patients who received neoadjuvant chemo-radiotherapy will be included
Exclusion
- Patients with American Society of Anesthesiologist (ASA) score 4 and 5.
- Patients with cardiac or chest problems that cannot withstand CO2 insufflation.
- Unresectable tumors (T4) (defined as those who cannot be resected without a high likelihood of leaving microscopic or gross residual disease at the local site because of tumor adherence or fixation).
- Obstructed or perforated cancer.
- Patients with unresectable metastatic rectal cancer.
Key Trial Info
Start Date :
May 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03242187
Start Date
May 25 2017
End Date
December 30 2019
Last Update
August 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology Center, Mansoura University
Al Mansurah, Egypt